1. Home
  2. ATON vs TCRT Comparison

ATON vs TCRT Comparison

Compare ATON & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlphaTON Capital Corp.

ATON

AlphaTON Capital Corp.

N/A

Current Price

$0.37

Market Cap

6.8M

Sector

Energy

ML Signal

N/A

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

HOLD

Current Price

$3.61

Market Cap

5.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATON
TCRT
Founded
1973
1998
Country
British Virgin Islands
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8M
5.7M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
ATON
TCRT
Price
$0.37
$3.61
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
539.3K
11.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$15,900,000.00
Revenue This Year
N/A
$5,680,500.00
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$1.31
52 Week High
$13.80
$5.48

Technical Indicators

Market Signals
Indicator
ATON
TCRT
Relative Strength Index (RSI) 35.90 75.69
Support Level $0.36 $2.45
Resistance Level $3.30 $3.76
Average True Range (ATR) 0.05 0.23
MACD 0.02 0.10
Stochastic Oscillator 10.83 94.17

Price Performance

Historical Comparison
ATON
TCRT

About ATON AlphaTON Capital Corp.

AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products. The company focuses on evaluating the impact of ALN1001, its primary program, and its derivatives on lipid deposition and gene expression. It aims to develop an oral obesity compound that addresses many of the shortcomings of injectable GLP-1 receptor agonists including preserving lean muscle mass.

Share on Social Networks: